Article PDF
Avoid common mistakes on your manuscript.
References
Karageorgopoulos DE, Falagas ME: Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008; 8: 751–762.
Wareham DW, Bean DC, Khanna P, et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 2008; 27: 607–612.
Poirel L, Nordmann P: Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826–836.
Qi C, Malczynski M, Parker M, et al. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J Clin Microbiol 2008; 46: 1106–1109.
Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003; 41: 3403–3406.
Gales AC, Pfaller MA, Sader HS, et al. Genotypic Characterization of carbapenem-nonsusceptible Acinetobacter spp. isolated in Latin America. Microb Drug Resist 2004; 10: 286–291.
Breier A, Martins AF: Surto de Multirresistência em Porto Alegre - Vigilância Epidemiológica de Casos. In: XVIII IEA World Congress of Epidemiology, Porto Alegre, Brazil, September 2008.
Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Approved standard M100-S16. Clinical and Laboratory Standards Institute, Wayne, 2007.
Woodford N, Ellington MJ, Coelho JM, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351–353.
Tenover FC, Arbeit RD, Goering RV: How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1997; 18: 426–439.
Baran G, Erbay A, Bodur H, et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis 2008; 12: 16–21.
Bou G, Cerveró G, Domínguez MA, et al. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of b-lactamases. J Clin Microbiol 2000; 38: 3299–3305.
Walther-Rasmussen J, Høiby N: OXA-type carbapenemases. J Antimicrob Chemother 2006; 57: 373–383.
Coelho JM, Turton JF, Kaufmann ME, et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006; 44: 3623–3627.
Villegas MV, Kattan JN, Correa A, et al. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian Hospitals. Antimicrob Agent Chemother 2007; 51: 2001–2004.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martins, A.F., Kuchenbecker, R., Sukiennik, T. et al. Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: Dissemination in Southern Brazil. Infection 37, 474–476 (2009). https://doi.org/10.1007/s15010-009-9003-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-009-9003-9